 |
PDBsum entry 2ypl
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system/viral protein
|
PDB id
|
|
|
|
2ypl
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
274 a.a.
|
 |
|
|
|
|
|
|
|
99 a.a.
|
 |
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
|
199 a.a.
|
 |
|
|
|
|
|
|
|
238 a.a.
|
 |
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural features underlying t-Cell receptor sensitivity to concealed mhc class i micropolymorphisms.
|
 |
|
Authors
|
 |
G.B.Stewart-Jones,
P.Simpson,
P.A.Van der merwe,
P.Easterbrook,
A.J.Mcmichael,
S.L.Rowland-Jones,
E.Y.Jones,
G.M.Gillespie.
|
 |
|
Ref.
|
 |
Proc Natl Acad Sci U S A, 2012,
109,
E3483.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Polymorphic differences distinguishing MHC class I subtypes often permit the
presentation of shared epitopes in conformationally identical formats but can
affect T-cell repertoire selection, differentially impacting autoimmune
susceptibilities and viral clearance in vivo. The molecular mechanisms
underlying this effect are not well understood. We performed structural,
thermodynamic, and functional analyses of a conserved T-cell receptor (TCR)
which is frequently expanded in response to a HIV-1 epitope when presented by
HLA-B*5701 but is not selected by HLA-B*5703, which differs from HLA-B*5701 by
two concealed polymorphisms. Our findings illustrate that although both HLA-B*57
subtypes display the epitope in structurally conserved formats, the impact of
their polymorphic differences occurs directly as a consequence of TCR ligation,
primarily because of peptide adjustments required for TCR binding, which
involves the interplay of polymorphic residues and water molecules. These minor
differences culminate in subtype-specific differential TCR-binding kinetics and
cellular function. Our data demonstrate a potential mechanism whereby the most
subtle MHC class I micropolymorphisms can influence TCR use and highlight their
implications for disease outcomes.
|
 |
|
|
|
|
 |